Dabigatran etexilate mesylate

Catalog No.S5960 Synonyms: Pradaxa, BIBR 1048MS, Dabigatran etexilate methanesulfonate

For research use only.

Dabigatran etexilate mesylate (Pradaxa, BIBR 1048MS, Dabigatran etexilate methanesulfonate) is an orally active prodrug of Dabigatran which is a reversible and selective, direct thrombin inhibitor (DTI). Dabigatran selectively and reversibly inhibits human thrombin with Ki of 4.5 nM and thrombin-induced platelet aggregation with IC50 of 10 nM.

Dabigatran etexilate mesylate Chemical Structure

CAS No. 872728-81-9

Selleck's Dabigatran etexilate mesylate has been cited by 1 Publication

Purity & Quality Control

Choose Selective Thrombin Inhibitors

Other Thrombin Products

Biological Activity

Description Dabigatran etexilate mesylate (Pradaxa, BIBR 1048MS, Dabigatran etexilate methanesulfonate) is an orally active prodrug of Dabigatran which is a reversible and selective, direct thrombin inhibitor (DTI). Dabigatran selectively and reversibly inhibits human thrombin with Ki of 4.5 nM and thrombin-induced platelet aggregation with IC50 of 10 nM.
Targets
human thrombin [1]
(Cell-free assay)
4.5 nM(Ki)

Protocol (from reference)

Solubility (25°C)

In vitro

DMSO 100 mg/mL
(138.15 mM)
Water Insoluble
Ethanol '''20 mg/mL

Chemical Information

Molecular Weight 723.84
Formula

C35H45N7O8S

CAS No. 872728-81-9
Storage 3 years -20°C powder
2 years -80°C in solvent

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment Interventions Conditions Sponsor/Collaborators Start Date Phases
NCT02839746 Completed -- Atrial Fibrillation Boehringer Ingelheim June 13 2016 --
NCT02684981 Completed -- Atrial Fibrillation|Stroke Boehringer Ingelheim November 11 2015 --
NCT02433366 Completed -- Atrial Fibrillation Boehringer Ingelheim January 2015 --
NCT01139658 Completed -- Venous Thromboembolism Boehringer Ingelheim August 2010 --

(data from https://clinicaltrials.gov, updated on 2022-01-17)

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Dabigatran etexilate mesylate | Dabigatran etexilate mesylate supplier | purchase Dabigatran etexilate mesylate | Dabigatran etexilate mesylate cost | Dabigatran etexilate mesylate manufacturer | order Dabigatran etexilate mesylate | Dabigatran etexilate mesylate distributor